Skip to content

Clinical trials

Completed Nervous System Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Status: Completed Country / region: Australia Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20152
20175
20184
20192
20202
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie5
Neuroscience Trials Australia4
PTC Therapeutics2
Abcuro, Inc.1
Alkahest, Inc.1
BeiGene USA, Inc.1
GlaxoSmithKline1
Inmune Bio, Inc.1
Mesoblast, Ltd.1
Quince Therapeutics S.p.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases20
Central Nervous System Diseases12
Brain Diseases11
Neurodegenerative Diseases7
Parkinson Disease5
Cardiovascular Diseases4
Cerebrovascular Disorders4
Movement Disorders4
Parkinsonian Disorders4
Stroke4

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.